JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265702

Human RABAC1 (PRA1) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

RABAC1 KO cell line available to order. KO validated by Western blot. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
2 Images
Western blot - Human RABAC1 (PRA1) knockout HeLa cell line (AB265702)
  • WB

Lab

Western blot - Human RABAC1 (PRA1) knockout HeLa cell line (AB265702)

Lanes 1-3 : Merged signal (red and green). Green - ab76413 observed at 21 kDa. Red - loading control ab7291 observed at 50 kDa.

ab76413 Anti-PRA1 antibody [EPR1747Y] was shown to specifically react with PRA1 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265702 (knockout cell lysate ab258162) was used. Wild-type and PRA1 knockout samples were subjected to SDS-PAGE. ab76413 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-PRA1 antibody [EPR1747Y] (<a href='/en-us/products/primary-antibodies/pra1-antibody-epr1747y-ab76413'>ab76413</a>) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human RABAC1 (PRA1) knockout HeLa cell lysate (<a href='/en-us/products/cell-lysates/human-rabac1-pra1-knockout-hela-cell-lysate-ab258162'>ab258162</a>) at 20 µg

Lane 3:

HEK293 cell lysate at 20 µg

Secondary

Lanes 1 - 3:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution

Lanes 1 - 3:

Western blot - Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/20000 dilution

Predicted band size: 21 kDa

Observed band size: 21 kDa,50 kDa

false

Sanger Sequencing - Human RABAC1 (PRA1) knockout HeLa cell line (AB265702)
  • Sanger seq

Unknown

Sanger Sequencing - Human RABAC1 (PRA1) knockout HeLa cell line (AB265702)

Homozygous : 1 bp deletion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1

Disease

Adenocarcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265702-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265702 Human RABAC1 (PRA1) knockout HeLa cell line", "number":"AB265702-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265702-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265702-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265702-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265702 Human RABAC1 (PRA1) knockout HeLa cell line", "number":"AB265702-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265702-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265702 Human RABAC1 (PRA1) knockout HeLa cell line", "number":"AB265702-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265702-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265702 Human RABAC1 (PRA1) knockout HeLa cell line", "number":"AB265702-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
RABAC1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PRA1 protein also known as prenylated Rab acceptor 1 is involved in vesicular transport processes within the cell. This protein has a molecular mass of approximately 21 kDa and plays an important role in the trafficking of proteins bound for various destinations in the secretory pathway. PRA1 is widely expressed in many tissues reflecting its integral function in cellular transport mechanisms.
Biological function summary

PRA1 interacts with Rab GTPases which suggest its role in facilitating the docking or fusion of transport vesicles with target membranes. Although it does not form a complex on its own PRA1 acts as an effector anchoring prenylated Rab proteins. This interaction is essential for maintaining the fidelity and specificity of vesicle transport events necessary for proper cellular functioning.

Pathways

PRA1 participates in the regulation of the Rab GTPase cycle and is important in the endocytic and secretory pathways. It modulates the activity of proteins such as Rab1 and Rab5 that coordinate the movement of vesicles from the endoplasmic reticulum to the Golgi and from the Golgi to the plasma membrane. These pathways are fundamental for cellular logistics ensuring that proteins reach the intracellular or extracellular locations where they are needed.

PRA1 has been linked to neurodegenerative conditions like Alzheimer's disease possibly due to its involvement in vesicular transport and protein trafficking dysregulation. Alterations in PRA1 expression or function can affect proteins such as Rab proteins potentially contributing to the pathological process of such disorders. Another condition associated with PRA1 is Charcot-Marie-Tooth disease suggesting its importance in neuronal maintenance and integrity.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com